Societal responsibilities of clinical trial sponsors. Lack of commercial pay off is not a legitimate reason for stopping a trial.
作者信息
Evans S, Pocock S
出版信息
BMJ. 2001 Mar 10;322(7286):569-70. doi: 10.1136/bmj.322.7286.569.
Abstract
摘要
相似文献
1
Societal responsibilities of clinical trial sponsors. Lack of commercial pay off is not a legitimate reason for stopping a trial.临床试验申办者的社会责任。缺乏商业回报并非终止试验的正当理由。
BMJ. 2001 Mar 10;322(7286):569-70. doi: 10.1136/bmj.322.7286.569.
2
Research funding.
Lancet. 1999 Jun 26;353(9171):2250. doi: 10.1016/S0140-6736(05)76309-1.
3
On transparency, responsibility, and accountability.论透明度、责任和问责制。
Clin Microbiol Infect. 2009 Dec;15(12):1100-2. doi: 10.1111/j.1469-0691.2009.02820.x.
4
Responsibilities of sponsors are limited in premature discontinuation of trials.
BMJ. 2001 Jul 7;323(7303):53.
5
Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002.1980 - 2002年英国非商业随机对照试验的描述性调查。
BMJ. 2003 Nov 1;327(7422):1017. doi: 10.1136/bmj.327.7422.1017.
6
Pharmaceutical company-sponsored drug trials: what are we to believe?制药公司赞助的药物试验：我们该相信什么？
J Clin Epidemiol. 2010 Feb;63(2):126-7. doi: 10.1016/j.jclinepi.2009.07.014.
7
Pharmaceutical company-sponsored drug trials: the system is broken.制药公司赞助的药物试验：该体系已失灵。
J Clin Epidemiol. 2010 Feb;63(2):128-9. doi: 10.1016/j.jclinepi.2009.07.015. Epub 2009 Oct 31.
8
Barriers to clinical trial enrollment: are state mandates the solution?临床试验入组的障碍：州政府强制规定是解决办法吗？
J Natl Cancer Inst. 2004 Jul 21;96(14):1048-9. doi: 10.1093/jnci/djh225.
9
[Independent research should be supported].应支持独立研究。
Ugeskr Laeger. 2003 Oct 27;165(44):4237; author reply 4237-8.
10
Authorship selection in industry-sponsored publications of dermatology clinical trials.皮肤科临床试验行业资助出版物中的作者选择
Br J Dermatol. 2017 Jun;176(6):1669-1671. doi: 10.1111/bjd.15459. Epub 2017 May 11.
引用本文的文献
1
The Influence of Industry Affiliation on Randomized Controlled Trials of Platelet-Rich Plasma for Knee Osteoarthritis.行业关联对富血小板血浆治疗膝关节骨关节炎随机对照试验的影响。
Am J Sports Med. 2023 Nov;51(13):3583-3590. doi: 10.1177/03635465221140917. Epub 2023 Jan 3.
2
A Mixed-Methods Cluster-Randomized Controlled Trial of a Hospital-Based Psychosocial Stimulation and Counseling Program for Caregivers and Children with Severe Acute Malnutrition.一项针对严重急性营养不良儿童及其照料者的基于医院的心理社会刺激与咨询项目的混合方法整群随机对照试验。
Curr Dev Nutr. 2021 Jul 21;5(8):nzab100. doi: 10.1093/cdn/nzab100. eCollection 2021 Aug.
3
Wrongful termination: lessons from the Geron clinical trial.不当解雇：来自杰龙公司临床试验的教训。
Stem Cells Transl Med. 2014 Dec;3(12):1398-401. doi: 10.5966/sctm.2014-0147. Epub 2014 Oct 8.
4
Finer nuances of clinical study agreements for research trials.研究试验临床研究协议的细微差别。
Indian J Ophthalmol. 2008 Jul-Aug;56(4):267-8. doi: 10.4103/0301-4738.41409.
5
Stopping trials early for commercial reasons: the risk-benefit relationship as a moral compass.因商业原因提前终止试验：风险效益关系作为道德指南。
J Med Ethics. 2005 Jul;31(7):410-4. doi: 10.1136/jme.2004.008771.
6
Institutional ethics review of clinical study agreements.临床研究协议的机构伦理审查。
J Med Ethics. 2004 Feb;30(1):30-4. doi: 10.1136/jme.2003.005199.
7
Responsibilities of sponsors are limited in premature discontinuation of trials.
BMJ. 2001 Jul 7;323(7303):53.
本文引用的文献
1
Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility.因与疗效、安全性或可行性无关的原因而提前终止临床试验。
BMJ. 2001 Mar 10;322(7286):603-5. doi: 10.1136/bmj.322.7286.603.
2
The agonising negative trend in monitoring of clinical trials.临床试验监测中令人痛苦的负面趋势。
Lancet. 1999 Dec 4;354(9194):1983-8. doi: 10.1016/S0140-6736(99)03464-9.
3
4
Monitoring of clinical trials: issues and recommendations.
Control Clin Trials. 1993 Jun;14(3):183-97. doi: 10.1016/0197-2456(93)90002-u.
5
When to stop a clinical trial.何时停止临床试验。
BMJ. 1992 Jul 25;305(6847):235-40. doi: 10.1136/bmj.305.6847.235.
Zotero 插件